APA

McCallister S., Valdez H., Curry K., MacGregor T., Borin M., Freimuth W., Wang Y. & Mayers D. L. (20050906). A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients. : Journal of acquired immune deficiency syndromes (1999).

Chicago

McCallister Scott, Valdez Hernan, Curry Kevin, MacGregor Thomas, Borin Marie, Freimuth William, Wang Yenyung and Mayers Douglas L. 20050906. A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients. : Journal of acquired immune deficiency syndromes (1999).

Harvard

McCallister S., Valdez H., Curry K., MacGregor T., Borin M., Freimuth W., Wang Y. and Mayers D. L. (20050906). A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients. : Journal of acquired immune deficiency syndromes (1999).

MLA

McCallister Scott, Valdez Hernan, Curry Kevin, MacGregor Thomas, Borin Marie, Freimuth William, Wang Yenyung and Mayers Douglas L. A 14-day dose-response study of the efficacy, safety, and pharmacokinetics of the nonpeptidic protease inhibitor tipranavir in treatment-naive HIV-1-infected patients. : Journal of acquired immune deficiency syndromes (1999). 20050906.